Cybin (HELP) Depreciation & Amortization (CF) (2020 - 2025)
Cybin's (HELP) quarterly Depreciation & Amortization (CF) came in at $22000.0 in Q4 2025, down 76.72% YoY from $94492.1 in Q4 2024, and down 24.14% on a QoQ basis from $29000.0 in Q3 2025.
Cybin (HELP) Depreciation & Amortization (CF) (2020 - 2025) Analysis & Trends
Cybin (HELP) has 6 years of Depreciation & Amortization (CF) data on file, last reported at $22000.0 in Q4 2025.
- Quarterly Depreciation & Amortization (CF) fell 76.72% year-over-year to $22000.0 in Q4 2025, while the trailing twelve-month figure through Mar 2026 was $89000.0 (down 70.35% YoY) and the FY2023 annual result came in at $36915.1, up 125.73% from the prior year.
- Depreciation & Amortization (CF) declined to $22000.0 in Q4 2025, from $29000.0 in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $104826.6 in Q3 2024 to a low of -$56037.0 in Q1 2023.
- A 5-year average of $44053.1 and a median of $38000.0 in 2025 frame the typical range for Depreciation & Amortization (CF).
- Annual changes were most pronounced in 2021 — Depreciation & Amortization (CF) surged 250.06% — and 2023, when it slumped 1051.88%.
- Tracing HELP's Depreciation & Amortization (CF) over 5 years: stood at $34906.8 in 2021, then surged by 49.84% to $52305.9 in 2022, then surged by 99.41% to $104304.0 in 2023, then retreated by 9.41% to $94492.1 in 2024, then slumped by 76.72% to $22000.0 in 2025.
- The last three Depreciation & Amortization (CF) figures came in at $22000.0 (Q4 2025), $29000.0 (Q3 2025), and $38000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 56.50 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 123.70 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 2.10 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 40.52 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 3.18 Mn |
| 10 | Cybin | 417.29 Mn | 417.29 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 22,000.00 |
| Dec 31, 2025 | 22,000.00 |
| Sep 30, 2025 | 29,000.00 |
| Sep 30, 2025 | 29,000.00 |
| Jun 30, 2025 | 38,000.00 |
| Jun 30, 2025 | 38,000.00 |
| Dec 31, 2024 | 94,492.09 |
| Dec 31, 2024 | 94,492.09 |
| Sep 30, 2024 | 104,826.64 |
| Sep 30, 2024 | 104,826.64 |
| Jun 30, 2024 | 100,897.40 |
| Jun 30, 2024 | 100,897.40 |
| Dec 31, 2023 | 104,304.04 |
| Dec 31, 2023 | 104,304.04 |
| Sep 30, 2023 | 52,961.06 |
| Sep 30, 2023 | 52,961.06 |
| Jun 30, 2023 | 51,367.22 |
| Jun 30, 2023 | 51,367.22 |
| Feb 28, 2023 | -56,036.99 |
| Feb 28, 2023 | -56,036.99 |